Does PANITUMUMAB Cause Hypomagnesaemia? 611 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 611 reports of Hypomagnesaemia have been filed in association with PANITUMUMAB (Vectibix). This represents 5.6% of all adverse event reports for PANITUMUMAB.
611
Reports of Hypomagnesaemia with PANITUMUMAB
5.6%
of all PANITUMUMAB reports
63
Deaths
117
Hospitalizations
How Dangerous Is Hypomagnesaemia From PANITUMUMAB?
Of the 611 reports, 63 (10.3%) resulted in death, 117 (19.1%) required hospitalization, and 46 (7.5%) were considered life-threatening.
Is Hypomagnesaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PANITUMUMAB. However, 611 reports have been filed with the FAERS database.
What Other Side Effects Does PANITUMUMAB Cause?
Rash (1,392)
Diarrhoea (1,123)
Death (767)
Dermatitis acneiform (758)
Neutropenia (757)
Skin toxicity (728)
Neuropathy peripheral (613)
Nausea (608)
Disease progression (600)
Colorectal cancer metastatic (583)
What Other Drugs Cause Hypomagnesaemia?
OMEPRAZOLE (1,766)
PANTOPRAZOLE (1,246)
ESOMEPRAZOLE (591)
CARBOPLATIN (586)
LANSOPRAZOLE (504)
FUROSEMIDE (501)
FLUOROURACIL (477)
METFORMIN (415)
CISPLATIN (395)
OXALIPLATIN (373)
Which PANITUMUMAB Alternatives Have Lower Hypomagnesaemia Risk?
PANITUMUMAB vs PANOBINOSTAT
PANITUMUMAB vs PANTOPRAZOLE
PANITUMUMAB vs PANTOPRAZOLE ANHYDROUS
PANITUMUMAB vs PANTOTHENIC ACID
PANITUMUMAB vs PAPAVERINE